Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Minerva Utate"'
Publikováno v:
Neuro Oncol
BACKGROUND Data related to the prevalence of different psychiatric disorders and their impact on survival and compliance in patients with glioma is scarce and mostly anecdotal. We aimed to study the prevalence of psychiatric disorders in glioma patie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::12ed74ca85a44b786891399115c1a22b
https://europepmc.org/articles/PMC6846933/
https://europepmc.org/articles/PMC6846933/
Autor:
Amie Patel, David Zagzag, Broderick Corless, John G. Golfinos, Malcolm Delara, George Karlin-Neumann, Christine Cordova, Jennifer M. Wiggins, Minerva Utate, Andrew S. Chi, Zacharia Sawaged, Jessica Schafrick, Sylvia Kurz, Matija Snuderl, Rajan Jain, David Polsky, Dimitris G. Placantonakis, Joshua S. Silverman, Mahrukh M. Syeda
Publikováno v:
Clinical Cancer Research. 26:A65-A65
Introduction: Liquid biopsies, especially plasma cell-free circulating tumor DNA (ctDNA), provide a potential opportunity to be a noninvasive biomarker for the diagnosis and monitoring of glioblastoma (GBM) patients. Previously, we detected TERT prom
Publikováno v:
Neuro Oncol
BACKGROUND Younger age and higher performance status are strong positive predictors of longer survival in patients with high-grade gliomas. In many cancers, disparities in race, gender, socioeconomic background, and immigration status were shown to i
Autor:
Amie Patel, Mahrukh M. Syeda, Broderick Corless, Sylvia Kurz, Joshua S. Silverman, Matija Snuderl, George Karlin-Neumann, Rajan Jain, Zacharia Sawaged, John G. Golfinos, Jessica Schafrick, Minerva Utate, Andrew S. Chi, David Polsky, Dimitris G. Placantonakis, Malcolm Delara, Christine Cordova, Jennifer M. Wiggins, David Zagzag, Yongzhao Shao
Publikováno v:
Journal of Clinical Oncology. 37:2026-2026
2026 Background: There is a critical need for more specific and less invasive diagnostic and pharmacodynamic biomarkers in glioblastoma (GBM) patients (pts). Previously, we detected TERT promoter hotspot mutations (C228T and C250T) in the ctDNA of ID
Autor:
Anurag Chandra, Milan Potmesil, Richard Y. Chang, Elliot Newman, Franco M. Muggia, Howard S. Hochster, Minerva Utate, Mengling Liu, Leon H. Pachter, Deirdre Jill Cohen, Bernadine Donahue, Theresa Ryan, Spiros P. Hiotis, Syma Iqbal
Publikováno v:
Annals of Surgical Oncology. 19:478-485
Chemoradiation after surgery for locally advanced gastric cancer improves overall and relapse-free survival compared with observation. However, locoregional recurrences remain high. Accordingly, we instituted this pilot/feasibility study, including i
Autor:
Joan Sorich, Samir S. Taneja, Franco M. Muggia, Janet F. Y. Lee, Abraham Chachoua, Minerva Utate, A. Hamilton, Sanjeev Sewak
Publikováno v:
Anti-Cancer Drugs. 14:67-72
Anti-tubulin couplets have activity in hormone-resistant prostate cancer. This study was designed to define the dose-limiting toxicity (DLT) and recommended phase II dose (RPTD) of the unique triplet combination of paclitaxel, estramustine phosphate
Autor:
Julia, Smith, Asma, Dilawari, Giske, Ursin, Eleni, Andreopoulou, Christina, Checka, Deborah, Axelrod, Amber, Guth, Hildegard, Toth, Minerva, Utate, Karen, Carapetyan, Elsa, Reich, Thomas, Diflo, Franco, Muggia
Publikováno v:
Anticancer research. 32(4)
Tamoxifen or raloxifen for 5 years reduces the risk of developing invasive breast cancer by 40%. To address safety concerns and seek enhanced efficacy, studies of new chemopreventive agents using mammographic density as a surrogate end point are attr
Autor:
Minerva Utate, A Dilawari, Julia Smith, John P. Curtin, M. Alvear, Karen Carapetyan, F. Muggia, Stephanie V. Blank, L Baer
Publikováno v:
ecancermedicalscience
Introduction We describe a screening and prevention programme primarily targeting under-served minority women at high risk of breast and/or ovarian cancer. Women attending this Bellevue Hospital Center (BHC) Clinic were either self-referred from a va
Publikováno v:
Journal of Clinical Oncology. 22:6127-6127
6127 Background: Our Women's Cancer Screening and Prevention Project, a multidisciplinary cancer risk assessment clinic, was launched in April 2001. Our objective was to determine the demand for a ...